Monarch Partners Asset Management’s BioLife Solutions BLFS Stock Holding History

Monarch Partners Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.47M	Buy	135,787 +384	+0.3%	+$7.93K	0.73%	57
2022 Q3	$3.08M	Buy	135,403 +35,665	+36%	+$763K	0.93%	39
2022 Q2	$1.38M	Buy	99,738 +44,825	+82%	+$658K	0.38%	120
2022 Q1	$1.25M	Hold	54,913	–	–	0.28%	132
2021 Q4	$2.05M	Buy	54,913 +4,647	+9%	+$199K	0.42%	115
2021 Q3	$2.13M	Sell	50,266 -14,209	-22%	-$684K	0.31%	113
2021 Q2	$2.87M	Buy	+64,475	New	+$2.27M	0.41%	87

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Monarch Partners Asset Management's BLFS Position: Q4 2022 in Review

Monarch Partners Asset Management increased its BioLife Solutions (BLFS) stake by 0.28% in Q4 2022, buying an estimated $7.93K and bringing the position to 135,787 shares worth $2.47M. The position accounts for 0.73% of the portfolio, ranked #57.

Monarch Partners Asset Management first reported a position in BLFS in Q2 2021 and has held it in 7 quarters since. The position peaked at $3.08M in Q3 2022. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

Monarch Partners Asset Management held 135,787 shares of BioLife Solutions worth $2.47M as of Q4 2022.
Monarch Partners Asset Management bought 384 BioLife Solutions shares in Q4 2022, an estimated $7.93K.
BioLife Solutions made up 0.73% of Monarch Partners Asset Management's portfolio in Q4 2022, its #57 holding.
Monarch Partners Asset Management first reported a position in BioLife Solutions in Q2 2021 and has held it in 7 quarters since.
Monarch Partners Asset Management's BioLife Solutions position peaked at $3.08M in Q3 2022.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.